Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating plasma corticotrophin-releasing factor-like immunoreactivity.

M J Ellis1, J H Livesey, R A Donald

  • 1Department of Endocrinology, Princess Margaret Hospital, Christchurch, New Zealand.

The Journal of Endocrinology
|May 1, 1988
PubMed
Summary

Direct radioimmunoassay (RIA) for human corticotrophin-releasing factor (CRF) in plasma yields inaccurate results due to interfering substances. These factors alter CRF measurements, especially in normal human plasma, unlike in equine or ovine plasma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a Telehealth Intervention to Improve Access to Live Donor Kidney Transplantation.

Transplantation proceedings·2019
Same author

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer.

Oncogene·2016
Same author

The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states.

BMC biology·2016
Same author

Predicting response and survival in chemotherapy-treated triple-negative breast cancer.

British journal of cancer·2014
Same author

Effect of vitamin D3 supplementation on Staphylococcus aureus nasal carriage: a randomized, double-blind, placebo-controlled trial in healthy adults.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2013

Area of Science:

  • Endocrinology
  • Biochemistry
  • Immunology

Background:

  • Direct radioimmunoassay (RIA) is commonly used to measure hormone levels.
  • Human corticotrophin-releasing factor (CRF) plays a crucial role in the stress response.
  • Accurate measurement of CRF in plasma is essential for understanding various physiological and pathological conditions.

Purpose of the Study:

  • To investigate the reliability of direct RIA for measuring human CRF in peripheral plasma.
  • To identify potential interfering substances in human plasma that affect CRF measurements.
  • To compare CRF-like immunoreactivity (CRF-LI) in human, equine, and ovine plasma.

Main Methods:

  • Direct RIA using seven different antisera for human CRF.
  • Parallel dilution studies with synthetic human CRF-41.

Related Experiment Videos

  • Plasma fractionation using Sephadex G-75 and Sephacryl S-200 chromatography.
  • Methanol treatment of plasma samples.
  • Incubation of 125I-labelled human CRF-41 with human plasma.
  • Main Results:

    • Normal human plasma exhibited high CRF-like immunoreactivity (CRF-LI) that did not parallel synthetic CRF-41.
    • The majority of CRF-LI in human plasma was of large molecular size (approx. 29,000 Da).
    • Methanol treatment reduced CRF-LI in normal plasma but not in late pregnancy plasma.
    • Added labelled human CRF-41 showed altered molecular size and reduced binding in human plasma.

    Conclusions:

    • Direct RIA of unextracted human plasma for CRF provides spurious results.
    • Human plasma contains interfering factors or binding substances affecting CRF measurement.
    • These interfering substances are not consistently observed in equine or ovine plasma.
    • Further purification or modified assay methods are necessary for accurate human plasma CRF quantification.